Forecasted cost growth was highest in fully insured arrangements, consistent with constrained data rights; only about 60% felt able to audit full claims files. Employers with complete claims data ...
Post–CAR T relapse in MCL is associated with median PFS ~2.5 months and OS ~5.4 months, underscoring a high-need salvage setting without an established standard. Relapse biopsy demonstrated retained ...
Effective October 13, 2026, federal financial participation is barred for specified pharmacologic and surgical interventions for Medicaid beneficiaries under 18 and CHIP enrollees under 19. CMS ...
The disparity in outcomes between pediatric and young adult patients with ALL is multifactorial, explained Emily K. Curran, MD. Emily K. Curran, MD, associate professor of internal medicine at the ...
The data debunks a persistent theory that Medicare Advantage enrolls healthier, lower-cost patients: nearly 68% of full-risk MA beneficiaries and 63% of fee-for-service MA beneficiaries lived in areas ...
A narrative review found obesity independently worsens psoriasis severity and blunts response to fixed-dose biologics, ...
Presidential directive reinstates a stayed 11-disease schedule outside ACIP, potentially sidestepping ongoing litigation while compressing review into an HHS-led 90-day planning process. Core ...
Setmelanotide produced a mean body mass index (BMI) reduction of 16.5% in patients with acquired hypothalamic obesity, compared with a 3.3% increase among those receiving placebo, according to trial ...
A large UK cohort study found atopic dermatitis raises the risk of shingles by 28%, with the steepest risk in severe disease ...
Brittany G. Craiglow, MD, FAAD, discusses JAK inhibitor hesitancy in pediatric alopecia areata, boxed warnings, and why step ...
Katherine Wilemon, Family Heart Foundation, described the biggest unmet need when it comes to public awareness of Lp(a) and ...
The FDA approved Moderna’s Biologics License Application (BLA) for its mRNA-based flu vaccine, mRNA-1010 (mFlusiva; Moderna), ...